PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,436,000 | -4.8% | 2,042,988 | -12.0% | 0.00% | 0.0% |
| Q2 2020 | $6,760,000 | -18.1% | 2,322,843 | -20.7% | 0.00% | -40.0% |
| Q1 2020 | $8,256,000 | -26.8% | 2,927,421 | -15.7% | 0.01% | -16.7% |
| Q4 2019 | $11,273,000 | +42.1% | 3,473,945 | -5.4% | 0.01% | +20.0% |
| Q3 2019 | $7,932,000 | -31.2% | 3,672,122 | -0.1% | 0.01% | -28.6% |
| Q2 2019 | $11,537,000 | -10.6% | 3,674,141 | +5.9% | 0.01% | -12.5% |
| Q1 2019 | $12,906,000 | +17.0% | 3,469,142 | -8.8% | 0.01% | 0.0% |
| Q4 2018 | $11,033,000 | +9.2% | 3,804,469 | -1.0% | 0.01% | +14.3% |
| Q3 2018 | $10,105,000 | +20.8% | 3,841,873 | +7.4% | 0.01% | +16.7% |
| Q2 2018 | $8,367,000 | -17.1% | 3,575,598 | +4.1% | 0.01% | -25.0% |
| Q1 2018 | $10,094,000 | +17.6% | 3,433,185 | +9.6% | 0.01% | +14.3% |
| Q4 2017 | $8,581,000 | -20.1% | 3,131,719 | -1.2% | 0.01% | -22.2% |
| Q3 2017 | $10,746,000 | +51.2% | 3,169,759 | +10.2% | 0.01% | +28.6% |
| Q2 2017 | $7,107,000 | +36.5% | 2,877,105 | +25.5% | 0.01% | +40.0% |
| Q1 2017 | $5,205,000 | +21.0% | 2,292,624 | +13.0% | 0.01% | 0.0% |
| Q4 2016 | $4,303,000 | -23.4% | 2,029,351 | +21.1% | 0.01% | -28.6% |
| Q3 2016 | $5,615,000 | +7.8% | 1,675,880 | +1.0% | 0.01% | 0.0% |
| Q2 2016 | $5,209,000 | -9.5% | 1,658,774 | -4.0% | 0.01% | -12.5% |
| Q1 2016 | $5,755,000 | -10.4% | 1,728,156 | -4.7% | 0.01% | -11.1% |
| Q4 2015 | $6,423,000 | -24.6% | 1,814,326 | +7.2% | 0.01% | -30.8% |
| Q3 2015 | $8,514,000 | -17.9% | 1,692,537 | +4.9% | 0.01% | -7.1% |
| Q2 2015 | $10,372,000 | -8.8% | 1,612,956 | -0.2% | 0.01% | -12.5% |
| Q1 2015 | $11,370,000 | +14.5% | 1,616,179 | +25.5% | 0.02% | +6.7% |
| Q4 2014 | $9,928,000 | +20.5% | 1,287,645 | +16.7% | 0.02% | +7.1% |
| Q3 2014 | $8,241,000 | -37.7% | 1,103,185 | -19.3% | 0.01% | -36.4% |
| Q2 2014 | $13,232,000 | +21.0% | 1,366,861 | +3.9% | 0.02% | +10.0% |
| Q1 2014 | $10,934,000 | +1.1% | 1,315,743 | +2.7% | 0.02% | -4.8% |
| Q4 2013 | $10,814,000 | +78.0% | 1,281,248 | +70.4% | 0.02% | +75.0% |
| Q3 2013 | $6,075,000 | +25.3% | 751,763 | +20.9% | 0.01% | +9.1% |
| Q2 2013 | $4,849,000 | – | 621,616 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |